Abstract

Erythropoietin (EPO), the cytokine required for erythrocyte production, contributes to muscle progenitor cell proliferation and delay myogenic differentiation. However, the underlying mechanism is not yet fully understood. Here, we report that EPO changes the skeletal myogenic regulatory factor expression program and delays differentiation via induction of GATA-4 and the basic helix-loop-helix TAL1 and that knockdown of both factors promotes differentiation. EPO increases the Sirt1 level, a NAD(+)-dependent deacetylase, and also induces the NAD(+)/NADH ratio that further increases Sirt1 activity. Sirt1 knockdown reduced GATA-4 and TAL1 expression, impaired EPO effect on delayed myogenic differentiation, and the Sirt1 knockdown effect was abrogated when combined with overexpression of GATA-4 or TAL1. GATA-4 interacts with Sirt1 and targets Sirt1 to the myogenin promoter and represses myogenin expression, whereas TAL1 inhibits myogenin expression by decreasing MyoD binding to and activation of the myogenin promoter. Sirt1 was found to bind to the GATA-4 promoter to directly regulate GATA-4 expression and GATA-4 binds to the TAL1 promoter to regulate TAL1 expression positively. These data suggest that GATA-4, TAL1, and Sirt1 cross-talk each other to regulate myogenic differentiation and mediate EPO activity during myogenic differentiation with Sirt1 playing a role upstream of GATA-4 and TAL1. Taken together, our findings reveal a novel role for GATA-4 and TAL1 to affect skeletal myogenic differentiation and EPO response via cross-talk with Sirt1.

Highlights

  • Erythropoietin regulates the myogenic regulatory factor expression program and proliferation

  • We found GATA-4 to be expressed at the highest level in myoblasts compared with GATA-3, and GATA-6 appeared to be an order of magnitude lower

  • T-cell acute leukemia 1 (TAL1) overexpression did not increase Sirt1 binding to the myogenin promoter (Fig. 7D), we found that increased TAL1 decreased MyoD binding to the myogenin promoter and knocking down TAL1 enhanced the binding of MyoD to the myogenin promoter (Fig. 7G), suggesting that TAL1 inhibits myogenin expression possibly by blocking MyoD binding to the myogenin promoter and, inhibits MyoD transcription activation of myogenin expression, which is required for myogenic differentiation

Read more

Summary

Background

Erythropoietin regulates the myogenic regulatory factor expression program and proliferation. We previously reported that EPO up-regulates Myf and MyoD and contributes myoblast proliferation, but inhibits myogenin expression and retards myogenic differentiation and myotube formation [13]. TAL1 was recently found decreased in Sirt1Ϫ/Ϫ embryonic stem cells that exhibit delayed hematopoietic differentiation [30], whereas forced expression of TAL1 in myoblasts was reported to block myogenic differentiation [31, 32] It has not yet been determined how endogenous GATA factors and TAL1 regulate myoblast differentiation in skeletal muscle. Our findings first demonstrate the new function of GATA-4 and TAL1 in regulating skeletal myogenic differentiation via cross-talk with Sirt and their targeted action and importance in myoblasts response to EPO

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call